期刊文献+

新型冠状病毒S蛋白抗体的制备及初步应用 被引量:4

Preparation and preliminary application of antiserum against S protein of SARS-CoV-2
原文传递
导出
摘要 目的制备新型冠状病毒S蛋白抗体,初步建立检测新型冠状病毒灭活疫苗抗原含量的方法。方法使用新型冠状病毒重组S蛋白分别免疫羊和兔,获得抗血清。采用间接ELISA法和微量中和试验检测抗血清效价,免疫印迹试验检测抗体特异性。采用蛋白G纯化树脂分别对羊和兔抗血清进行亲和层析纯化,获得抗体。以纯化后的羊抗体作为包被抗体,兔抗体作为显示抗体,建立新型冠状病毒灭活疫苗抗原含量检测方法。结果对羊进行4次免疫后,抗血清ELISA效价达220000,中和抗体效价达1536。对兔进行3次免疫后,抗血清ELISA效价达220000,中和抗体效价达4096。羊和兔抗体均可与新型冠状病毒S蛋白特异性结合。应用纯化后的抗体,成功建立了检测抗原含量的双抗体夹心ELISA方法,该方法线性良好,R^(2)>0.99,可用于新型冠状病毒灭活疫苗原液抗原含量的检测。结论成功制备了羊和兔抗新型冠状病毒S蛋白高效价抗体,并初步建立了新型冠状病毒灭活疫苗抗原含量检测的双抗体夹心ELISA方法。 Objective To prepare antiserum against S protein of SARS-CoV-2 and preliminarily develop a method for determination of antigen content in inactivated SARS-CoV-2 vaccine.Methods Goats and rabbits were immunized with recombinant S protein of SARS-CoV-2,and the obtained antisera were determined for titer by indirect ELISA and neutralization assay and for specificity by Western blot,then purified by protein G resin affinity chro-matography.A sandwich ELISA for determination of antigen content of inactivated SARS-CoV-2 vaccine was developed by using purified goat antibody as capture antibody and purified rabbit antibody as detection antibody.Results The titer of antiserum of goats after immunization for 4 times reached 220000 by ELISA and 1536 by neutralization assay,while that of rabbits after immunization for 3 times reached 220000 by ELISA and 4096 by neutralization assay.Both goat and rabbit antibodies showed specific binding to the S protein of SARS-CoV-2.A double antibody sandwich ELISA method for determination of antigen content was successfully developed by using the purified antibodies,which showed a good linearity with a R^(2) value of more than 0.99.Conclusion High titer goat and rabbit antisera against S protein of SARSCoV-2 were prepared successfully,and double antibody sandwich ELISA method for determination of antigen content of inactivated SARS-CoV-2 vaccine was preliminarily developed.
作者 徐康维 何蕊 权娅茹 苏喆 王剑锋 赵慧 李长贵 XU Kang-wei;HE Rui;QUAN Ya-ru;SU Zhe;WANG Jian-feng;ZHAO Hui;LI Chang-gui(Division of Respiratory Virus Vaccines,National Institutes for Food and Drug Control,Beijing 102629,China;不详)
出处 《中国生物制品学杂志》 CAS CSCD 北大核心 2021年第7期857-861,共5页 Chinese Journal of Biologicals
基金 北京市自然科学基金(L192009)。
关键词 新型冠状病毒 抗血清效价 酶联免疫吸附试验 抗原含量 SARS-CoV-2 Antiserum titer ELISA Antigen content
  • 相关文献

参考文献4

二级参考文献10

共引文献35

同被引文献14

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部